• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

罗马尼亚注射吸毒者中与 HIV 相关的结核病发病率不断上升。

Increasing incidence of HIV- associated tuberculosis in Romanian injecting drug users.

机构信息

Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.

Victor Babes Clinical Hospital for Infectious and Tropical Diseases, Bucharest, Romania.

出版信息

HIV Med. 2018 May;19(5):316-323. doi: 10.1111/hiv.12576. Epub 2018 Feb 21.

DOI:10.1111/hiv.12576
PMID:29464834
Abstract

BACKGROUND

A high prevalence of tuberculosis (TB) among HIV-positive injecting drug users (IDUs) may fuel the TB epidemic in the general population of Romania. We determined the frequency and characteristics of TB in HIV-infected IDUs referred to a national centre.

METHODS

Prospective observational cohort study of all newly-diagnosed HIV-positive IDUs admitted to Victor Babes Hospital, Bucharest, between January 2009 and December 2014. Socio-demographics, clinical characteristics and outcomes of HIV/TB co-infected IDUs were compared to HIV-positive IDUs without TB.

RESULTS

170/598 (28.5%) HIV-infected IDUs were diagnosed with TB. The prevalence increased from 12.5% in 2009 to 32.1% in 2014 (P < 0.001). HIV/TB co-infected individuals had lower median CD4 cell counts 75 (vs. 450/mm , P < 0.0001) and higher median HIV viral loads 5.6 log (vs. 4.9 log , P < 0.0001) when presenting to healthcare services. 103/170 (60.6%) HIV/TB co-infected IDUs were diagnosed with pulmonary TB. Resistant Mycobacterium tuberculosis strains were common, with 18/105 (17.1%) of patients having Multi-Drug Resistant (MDR) disease. Higher mortality rate was associated with TB co-infection (P < 0.0001), extra-pulmonary TB (P = 0.0026) and extensively drug resistant TB (P = 0.024).

CONCLUSIONS

Tuberculosis (TB) is an increasing problem in HIV-infected IDUs in Romania. Presentation is often with advanced HIV, significant TB drug resistance and consequent outcomes are poor.

摘要

背景

罗马尼亚艾滋病毒阳性注射吸毒者(IDU)中结核病(TB)的高发率可能会助长该国普通人群中的 TB 流行。我们确定了转介至国家中心的 HIV 感染 IDU 中 TB 的频率和特征。

方法

这是一项针对 2009 年 1 月至 2014 年 12 月期间在布加勒斯特 Victor Babes 医院新诊断出的所有 HIV 阳性 IDU 的前瞻性观察性队列研究。比较了 HIV/TB 合并感染 IDU 与未感染 TB 的 HIV 阳性 IDU 的社会人口统计学、临床特征和结局。

结果

598 例 HIV 感染 IDU 中有 170 例(28.5%)诊断为 TB。2009 年至 2014 年,TB 合并感染的比例从 12.5%上升至 32.1%(P < 0.001)。就诊时,HIV/TB 合并感染个体的中位 CD4 细胞计数较低(75 个细胞/毫米 3,与 450 个细胞/毫米 3,P < 0.0001),中位 HIV 病毒载量较高(5.6 log ,与 4.9 log ,P < 0.0001)。170 例 HIV/TB 合并感染 IDU 中有 103 例(60.6%)诊断为肺结核。常见耐药结核分枝杆菌菌株,其中 18 例(17.1%)患者患有耐多药结核病(MDR)。TB 合并感染(P < 0.0001)、肺外结核(P = 0.0026)和广泛耐药结核病(P = 0.024)与更高的死亡率相关。

结论

罗马尼亚 HIV 感染 IDU 中结核病(TB)是一个日益严重的问题。就诊时通常 HIV 状况较为晚期,TB 药物耐药情况显著,且预后不良。

相似文献

1
Increasing incidence of HIV- associated tuberculosis in Romanian injecting drug users.罗马尼亚注射吸毒者中与 HIV 相关的结核病发病率不断上升。
HIV Med. 2018 May;19(5):316-323. doi: 10.1111/hiv.12576. Epub 2018 Feb 21.
2
Alarming increase in tuberculosis and hepatitis C virus (HCV) among HIV infected intravenous drug users.艾滋病毒感染的静脉吸毒者中结核病和丙型肝炎病毒(HCV)感染率惊人上升。
J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19625. doi: 10.7448/IAS.17.4.19625. eCollection 2014.
3
Clinical features of tuberculosis associated with HIV infection in Taiwan.台湾地区人类免疫缺陷病毒感染合并结核病的临床特征
J Formos Med Assoc. 1996 Dec;95(12):923-8.
4
Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: a nationwide population-based cohort study.注射吸毒对HIV-1感染患者高效抗逆转录病毒治疗反应的影响:一项基于全国人群的队列研究。
Scand J Infect Dis. 2010 Dec;42(11-12):917-23. doi: 10.3109/00365548.2010.511258. Epub 2010 Sep 15.
5
Recent HIV-1 Outbreak Among Intravenous Drug Users in Romania: Evidence for Cocirculation of CRF14_BG and Subtype F1 Strains.罗马尼亚静脉吸毒者中近期的HIV-1疫情:CRF14_BG和F1亚型毒株共同传播的证据
AIDS Res Hum Retroviruses. 2015 May;31(5):488-95. doi: 10.1089/aid.2014.0189. Epub 2014 Nov 4.
6
Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital.一家转诊医院中感染人类免疫缺陷病毒的注射吸毒者的病毒性肝炎血清流行率及感染并发症情况
J Microbiol Immunol Infect. 2008 Jun;41(3):200-8.
7
Mycobacterium tuberculosis and human immunodeficiency virus co-infection in intravenous drug users on admission to prison.入狱时静脉吸毒者中结核分枝杆菌与人类免疫缺陷病毒合并感染情况
Int J Tuberc Lung Dis. 2000 Jan;4(1):41-6.
8
T lymphocyte subpopulations and intestinal helminthes profile among tuberculosis patients co-infected with HIV before and after anti tubercular treatment at University of Gondar Hospital, Northwest Ethiopia.结核患者在抗结核治疗前后合并 HIV 感染时 T 淋巴细胞亚群和肠道蠕虫感染谱:来自埃塞俄比亚西北部贡德尔大学医院的研究
BMC Infect Dis. 2020 Feb 7;20(1):109. doi: 10.1186/s12879-020-4845-y.
9
Clinical correlate of tuberculosis in HIV co-infected children at the University of Abuja Teaching Hospital, Gwagwalada, Nigeria.尼日利亚瓜瓜瓦拉达阿布贾大学教学医院HIV合并感染儿童结核病的临床关联
Niger J Clin Pract. 2011 Apr-Jun;14(2):206-11. doi: 10.4103/1119-3077.84018.
10
The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis.注射吸毒史对开始联合抗逆转录病毒治疗的 HIV 阳性个体疾病进展和死亡的影响:合作队列分析。
HIV Med. 2012 Feb;13(2):89-97. doi: 10.1111/j.1468-1293.2011.00940.x. Epub 2011 Aug 7.

引用本文的文献

1
Joint Modeling of Longitudinal Outcome and Competing Risks: Application to HIV/AIDS Data.纵向结局和竞争风险的联合建模:在 HIV/AIDS 数据中的应用。
J Res Health Sci. 2023 Mar;23(1):e00571. doi: 10.34172/jrhs.2023.106.
2
Brain opportunistic infections and tumors in people living with HIV - still a challenge in efficient antiretroviral therapy era.艾滋病毒感染者的脑部机会性感染和肿瘤——在高效抗逆转录病毒治疗时代仍然是一个挑战。
J Neurovirol. 2023 Jun;29(3):297-307. doi: 10.1007/s13365-023-01135-1. Epub 2023 May 23.
3
A View of Human Immunodeficiency Virus Infections in the North-West Region of Romania.
罗马尼亚西北部的人类免疫缺陷病毒感染情况观察。
Medicina (Kaunas). 2019 Nov 29;55(12):765. doi: 10.3390/medicina55120765.